Evidence map›Paper›PMID 41282180›Full record

ArticleResearch square2025

Optimization of injections with speculum-compatible devices to deliver ethyl cellulose-ethanol into the cervix to treat cervical dysplasia.

Taya Lee, Vené Richardson-Powell, Gatha Adhikari, Brian Crouch, Nimmi Ramanujam, Jenna L Mueller

Abstract readPreprint
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Taya LeeUniversity of Maryland, College Park.
Vené Richardson-PowellUniversity of Maryland, College Park.
Gatha AdhikariUniversity of Maryland, College Park.
Brian CrouchDuke University.
Nimmi RamanujamDuke University.
Jenna L MuellerUniversity of Maryland, College Park.

Funding

Optimizing ablation of cervical precancer with ethyl cellulose ethanol to enable translation to women in low and middle-income countriesR44CA257303 · NCI · CALLA HEALTH FOUNDATION · PI CROUCH, BRIAN · 2023 to 2024
$1.8M
Image-guided ethyl cellulose ethanol ablation to enable treatment of cervical dysplasia in low and middle-income countriesR37CA302885 · NCI · UNIV OF MARYLAND, COLLEGE PARK · PI Jenna Lynne Hook Mueller · 2025 to 2026
$1.2M
NCI NIH HHS R37 CA302885NCI NIH HHS R44 CA257303
6 · The paper itself

Abstract

Intracervical injections directly delivery therapies into the cervix. We previously explored ethyl cellulose (EC)-ethanol intracervical injections as a treatment for cervical dysplasia in low- and middle-income countries. Here we: 1) compared swine and human cervices to assess swine as a model for intracervical injections, and 2) evaluated two speculum-compatible injectors: a custom single needle injector and an extender injector, assembled from off-the-shelf components, to determine what parameters produced optimal distribution. Mechanical properties of swine and human cervices were compared. Swine cervices were injected with EC-ethanol iohexol using both injectors. Distribution and leakage volumes in tissue was visualized with microCT and quantified with 3D Slicer. Mechanical testing showed swine and human cervical tissue yielded comparable storage and loss moduli (p > 0.05).

Indexed as

cervical dysplasiaethanol ablationethyl celluloseInjection deviceintracervical injection

Identifiers

PMID41282180
PMCPMC12633490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.